|
AbClon Inc
adenoviral vector (adv-vector Adenoviral Vector (Adv Vector, supplied by AbClon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vector++adv+vector/pmc04599270-157-11-15 Average 90 stars, based on 1 article reviews
adenoviral vector (adv-vector - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
replication incompetent adenoviral vector ![]() Replication Incompetent Adenoviral Vector, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/replication+incompetent+adenoviral+vector/pmc07910769-2-0-5 Average 90 stars, based on 1 article reviews
replication incompetent adenoviral vector - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
ViraQuest Inc
adenoviral vectors (green fluorescent protein [gfp] or ampka-ca ![]() Adenoviral Vectors (Green Fluorescent Protein [Gfp] Or Ampka Ca, supplied by ViraQuest Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectors+gfp/pm24917578-53-11-12 Average 90 stars, based on 1 article reviews
adenoviral vectors (green fluorescent protein [gfp] or ampka-ca - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Vaccitech Ltd
viral vectored vaccines ![]() Viral Vectored Vaccines, supplied by Vaccitech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectored+vaccines/pmc05926543-233-2-6 Average 90 stars, based on 1 article reviews
viral vectored vaccines - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Quantum Biotechnologies Inc
adenoviral shuttle vector padbn ![]() Adenoviral Shuttle Vector Padbn, supplied by Quantum Biotechnologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+shuttle+vector+padbn/us07244429-489-12-16 Average 90 stars, based on 1 article reviews
adenoviral shuttle vector padbn - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genvec Inc
adenovirus vectors ![]() Adenovirus Vectors, supplied by Genvec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectors/pm11228538-110-1-29 Average 90 stars, based on 1 article reviews
adenovirus vectors - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
SIRION Biotech
recombinant adenoviral vectors ad5(pro)-cmv-rsv-f ![]() Recombinant Adenoviral Vectors Ad5(pro) Cmv Rsv F, supplied by SIRION Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vector/pmc11522487-323-9-24 Average 90 stars, based on 1 article reviews
recombinant adenoviral vectors ad5(pro)-cmv-rsv-f - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Welgen Inc
adenoviral vectors ![]() Adenoviral Vectors, supplied by Welgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectors/pmc03419340-84-0-7 Average 90 stars, based on 1 article reviews
adenoviral vectors - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genzyme
recombinant adenoviruses ![]() Recombinant Adenoviruses, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectors/pmc01950465-362-13-6 Average 90 stars, based on 1 article reviews
recombinant adenoviruses - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genechem
recombinant adenoviral vector encoding mitofilin cdna ![]() Recombinant Adenoviral Vector Encoding Mitofilin Cdna, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/recombinant+adenoviral+vector+encoding+mitofilin+cdna/pmc09108246-59-1-14 Average 90 stars, based on 1 article reviews
recombinant adenoviral vector encoding mitofilin cdna - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genechem
hdac4 adenovirus ![]() Hdac4 Adenovirus, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/hdac4+gfp+adenoviral+vector++ad+hdac4+gfp+/pmc10325875-57-4-24 Average 90 stars, based on 1 article reviews
hdac4 adenovirus - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Shanghai Genechem Ltd
adenoviral vectors expressing saa1 (ad-saa1 ![]() Adenoviral Vectors Expressing Saa1 (Ad Saa1, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Adenoviral+Vectors/adenoviral+vectors+expressing+saa1++ad+saa1/pmc06503374-78-8-21 Average 90 stars, based on 1 article reviews
adenoviral vectors expressing saa1 (ad-saa1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Hematology & Oncology
Article Title: COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
doi: 10.1186/s13045-021-01046-w
Figure Lengend Snippet: Advantages and disadvantages of various types of COVID19 vaccines in development
Article Snippet:
Techniques: Plasmid Preparation, Introduce, Produced, Ex Vivo, Infection
Journal:
Article Title: Therapeutic Antitumor Response After Immunization with a Recombinant Adenovirus Encodinga Model Tumor-Associated Antigen
doi:
Figure Lengend Snippet: Two types of rAd, rAd-CMV1 and rAd-CMV2, were used in these studies. The back-bone vector is derived from the type 2 adenovirus. Both vectors have a complete E1A and partial E1B deletion spanning 356 to 3,327 bp. The LacZ gene is inserted into the E1 region under the control of the CMV immediate early promoter. rAd-CMV1 has no polyadenylation, while rAd-CMV2 has SV40 polyadenylation. In addition to the deletions in the E1 region, rAd-CMV2 has deletions in the E4 region spanning 32,177 to 32,815 bp and 34,082 to 35,575 bp.
Article Snippet: The authors thank the workers at
Techniques: Plasmid Preparation, Derivative Assay, Control
Journal: Frontiers in Cardiovascular Medicine
Article Title: Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
doi: 10.3389/fcvm.2022.823591
Figure Lengend Snippet: Reduced mitofilin expression is associated with the upregulation of pyroptosis-related factors in an acute myocardial infarction (AMI) model. (A) The percentage of myocardial infarction (MI) area increased in the AMI group. (B,C) The malondialdehyde (MDA) level and the lactate dehydrogenase (LDH) level were increased upon AMI induction. (D,E) The levels of interleukin (IL)-1β and IL-18 were increased in the AMI group. (F) Mitofilin protein levels were significantly decreased in the AMI group, while the protein levels of cleaved-caspase-1, nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3 (NLRP3), apoptosis-associated speck-like protein containing (ASC), Gasdermin D (GSDND) were increased. ** p < 0.01 and *** p < 0.001. ns: not significant.
Article Snippet: A
Techniques: Expressing, Binding Assay
Journal: Frontiers in Cardiovascular Medicine
Article Title: Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
doi: 10.3389/fcvm.2022.823591
Figure Lengend Snippet: Overexpression of mitofilin alleviates AMI. (A) The administration of adenovirus carrying mitofilin (ad-mitofilin) significantly increased the expression level of mitofilin in the myocardium. (B) The area of MI was partially reduced after the administration of ad-mitofilin. (C,D) MDA levels and LDH levels were partially reduced after the administration of ad-mitofilin. (E,F) IL-1β and IL-18 levels were partially reduced after the administration of ad-mitofilin. (G) After the administration of ad-mitofilin, the mitofilin protein level was significantly increased upon AMI induction, while the protein levels of cleaved- caspase-1, NLRP3, ASC, and GSDND protein levels were partially decreased. Sham vs AMI: ** P < 0.01 and *** P < 0.001. AMI vs AMI+ad-mitofilin: ### P < 0.001.
Article Snippet: A
Techniques: Over Expression, Expressing
Journal: Frontiers in Cardiovascular Medicine
Article Title: Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
doi: 10.3389/fcvm.2022.823591
Figure Lengend Snippet: Mitofilin knockdown exacerbates hypoxia/reoxygenation (H/R)-induced cell damage of H9C2 by regulating pyroptosis. (A) The expression level of mitofilin was strongly reduced after the administration of ad-si-mitofilin. (B,C) H/R induced the increase of MDA level and LDH level in H9C2 cells, while levels were further increased after the administration of ad-si-mitofilin. The presence of AC-YVAD-CMK (an inhibitor for caspase-1) suppressed the effect of mitofilin knockdown. (D,E) H/R induced the increase of IL-1β and IL-18 levels in H9C2 cells, which were further increased after the mitofilin knockdown. The presence of AC-YVAD-CMK suppressed the effect of mitofilin knockdown. (F) Mitofilin knockdown increased the protein levels of cleaved-caspase-1, NLRP3, ASC, and GSDND in H9C2 cells upon H/R induction, which was rescued by AC-YVAD-CMK. (G) H/R induction promoted cell death by increasing the percentage of cells with impaired membrane integrity [revealed by propidium iodide (PI) staining]. Mitofilin knockdown exacerbated cell death (with typical morphology of cell swelling and membrane rupture). AC-YVAD-CMK suppressed the effect of mitofilin knockdown. * P < 0.05, ** P < 0.01, and *** P < 0.001.
Article Snippet: A
Techniques: Expressing, Staining
Journal: Frontiers in Cardiovascular Medicine
Article Title: Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
doi: 10.3389/fcvm.2022.823591
Figure Lengend Snippet: Mitofilin regulates the PI3K/AKT signaling pathway. (A) The levels of p-PI3K and p-AKT in H9C2 cells were decreased after H/R induction, which were further decreased after the mitofilin knockdown. (B) The levels of p-PI3K and p-AKT in H9C2 cells were rescued after mitofilin overexpression. Con vs H/R: ** P < 0.01 and *** P < 0.001. H/R vs H/R+ad-si-mitofilin or ad-mitofilin: ### P < 0.001.
Article Snippet: A
Techniques: Over Expression
Journal: Frontiers in Cardiovascular Medicine
Article Title: Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
doi: 10.3389/fcvm.2022.823591
Figure Lengend Snippet: The protective effect of mitofilin in the H/R-induced H9C2 damage is dependent on PI3K activity. (A) Hypoxia/reoxygenation induced a decrease in the mitofilin expression level in H9C2 cells. The level of mitofilin protein was increased after mitofilin overexpression. (B,C) Hypoxia/reoxygenation induced increase of the MDA level and LDH level was partially reduced after mitofilin overexpression. The presence of GDC-0941 (a PI3K inhibitor) abrogated the rescue effect. (D,E) Hypoxia/reoxygenation induced the increase of IL-1β and IL-18 levels in H9C2 cells, and mitofilin overexpression reduced their levels. The presence of GDC-0941 abrogated the rescue effect. (F) Mitofilin overexpression suppressed the protein levels of cleaved-caspase-1, NLRP3, ASC, and GSDND in H9C2 cells upon H/R induction, and the effects were abrogated by GDC-0941. * P < 0.05, ** P < 0.01, and *** P < 0.001. ##: H/R vs H/R+ad-mitofilin: P < 0.01.
Article Snippet: A
Techniques: Activity Assay, Expressing, Over Expression
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) Immunofluorescence assay results showed that cells were positive for type II collagen (red) and negative for type I collagen (red, scale bar: 100 μm). b) The transfection efficiency in each group was observed by fluorescence microscopy. The empty adenovirus (EP) and histone deacetylase 4 (HDAC4) adenoviruses carried green fluorescent protein (GFP) (green); scale bar: 100 μm. c) Representative transfection rate of groups at 48 hours after transfection by flow cytometry. d) Data were quantified by the mean transfection rate (n = 3). FL1, FITC channel; M1, FITC positive cell rate.
Article Snippet:
Techniques: Immunofluorescence, Transfection, Fluorescence, Microscopy, Histone Deacetylase Assay, Flow Cytometry
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: Histone deacetylase 4 (HDAC4) markedly improves the survival rate and biofunction of chondrocytes. a) Representative protein expression levels of runt-related transcription factor 2 (RUNX2), type X collagen (Col-X), matrix metallopeptidase-13 (MMP-13), and β-actin in chondrocytes. b) Representative cell survival rates of groups were detected by real-time cell analysis (RTCA) assay; the HDAC4 group (purple) and the empty adenovirus (EP) group (grey), the data were quantified by mean cell index (CI) (n = 4). c) Representative EdU-based cell proliferation assay results. The EdU-positive cells showed red fluorescence. Scale bar: 50 μm. The percentage of EdU-positive cells in all cells and the percentage of EdU-positive cells in the cells with red fluorescence were quantified. d) Cell viability was detected by flow cytometry; of the four regions in the figure, zone V3 indicates negative 7-amino-actinomycin (7-AAD) and Annexin-V-phycoerythrin (PE) staining, showing the percentage of living cells, while zone V4 indicates negative 7-AAD staining and positive Annexin-V-PE staining, showing the percentage of early apoptosis cells. The data were quantified by the early apoptosis rate (n = 6). Data are expressed as the mean (standard deviation). ***p < 0.001. DAPI, 4′,6-diamidino-2-phenylindole; GFP, green fluorescent protein.
Article Snippet:
Techniques: Histone Deacetylase Assay, Expressing, Cell Analysis, Proliferation Assay, Fluorescence, Flow Cytometry, Staining, Standard Deviation
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) Volcano plot of the differentially expressed genes (DEGs) for empty adenovirus (EP) versus histone deacetylase 4 (HDAC4, wild-type (WT)-H4). The genes that were found to be statistically significant (false discovery rate ≤ 0.05) are highlighted. b) The bar chart shows the total DEGs, upregulated DEGs, and downregulated DEGs. c) Gene Ontology (GO) functional enrichment analysis of DEGs with or without HDAC4. BP, biological process; CC, cell component; MF, molecular function.
Article Snippet:
Techniques: Histone Deacetylase Assay, Functional Assay
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of differentially expressed genes (DEGs) with or without histone deacetylase 4 (HDAC4). b) KEGG pathway enrichment analysis of upregulated DEGs with or without HDAC4. MAPK, mitogen-activated protein kinase; padj, p-adjusted.
Article Snippet:
Techniques: Histone Deacetylase Assay
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) Volcano plot of the differentially expressed genes (DEGs) for empty adenovirus (EP) versus mutated histone deacetylase 4 (M_H4). The genes that were found to be statistically significant (false discovery rate ≤ 0.05) are highlighted; the bar chart shows the total DEGs, upregulated DEGs, and downregulated DEGs. b) Gene Ontology (GO) functional enrichment analysis of DEGs with or without mutated HDAC4. c) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs between the EP and mutated HDAC4 groups. d) KEGG pathway enrichment analysis of upregulated DEGs between the EP and mutated HDAC4 groups. e) Gene set enrichment analysis (GSEA) based on GO enrichment analysis showed the upregulated (red) and downregulated pathways (blue) comparing the mutated HDAC4 and EP groups. f) GSEA based on KEGG enrichment analysis comparing the mutated HDAC4 and EP groups. AMPK, AMP-activated protein kinase; BP, biological process; CC, cellular component; HTLV-I, human T-lymphotropic virus type 1; MF, molecular function; mRNA, messenger RNA; ncRNA, non-coding RNA; padj, p-adjusted; rRNA, ribosomal RNA.
Article Snippet:
Techniques: Histone Deacetylase Assay, Functional Assay, Virus
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) Volcano plots showing the differentially expressed genes (DEGs) of the ribosome pathway in the histone deacetylase 4 (HDAC4) groups and the genes that were found to be statistically significant (false discovery rate (FDR) ≤ 0.05). b) All DEGs, upregulated genes, and downregulated genes. c) Volcano plots showing the DEGs of the ribosome pathway in the HDAC4 groups, the genes that were found to be statistically significant (FDR ≤ 0.05). d) All DEGs, upregulated genes, and downregulated genes. e) Validation of the top ten genes by polymerase chain reaction (PCR) (n = 6). f) Validation of the top gene (CNOT1) by Western blotting (n = 3). The data are expressed as the mean (standard deviation). **p < 0.01, ***p < 0.001. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Article Snippet:
Techniques: Histone Deacetylase Assay, Biomarker Discovery, Polymerase Chain Reaction, Western Blot, Standard Deviation
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: a) The protein level of CNOT1 in normal and osteoarthritis (OA) cartilage tissue was detected by Western blotting (n = 3). b) The protein expression of CNOT1 in relatively normal and OA cartilage tissue was detected by immunohistochemistry (n = 3). c) Western blotting results showed the protein level of CNOT1 in the OA chondrocyte model (n = 3). d) Safranin O and fast green staining showed the degenerative degree of cartilage tissue, and immunohistochemistry results showed the protein expression of CNOT1 in OA rat models (n = 10). The data are expressed as the mean (standard deviation). **p < 0.01, ***p < 0.001. ACLT, anterior cruciate ligament transection; Con., control; IL, interleukin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HDAC4, histone deacetylase 4.
Article Snippet:
Techniques: Western Blot, Expressing, Immunohistochemistry, Staining, Standard Deviation, Control, Histone Deacetylase Assay
Journal: Bone & Joint Research
Article Title: Upregulated ribosome pathway plays a key role in HDAC4, improving the survival rate and biofunction of chondrocytes
doi: 10.1302/2046-3758.127.BJR-2022-0279.R2
Figure Lengend Snippet: Hypothesis schematic of the molecular mechanism by which histone deacetylase 4 (HDAC4) improves the survival rate and biological function of chondrocytes. rRNA, ribosomal RNA; TF_bZIP, transcription factor_basic leucine zipper zinc finger; ZBTB, BTB domain; zf-C2H2, zinc finger-C2H2.
Article Snippet:
Techniques: Histone Deacetylase Assay
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: Primer sequence for RT-qPCR
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Sequencing
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: SAA1 is associated with HFD-induced obesity. a , the heatmap of the top 10 DEGs screened out from the GSE39549 dataset. The abscissa indicates the sample number, the ordinate indicates the DEGs, and the upper right histogram is the color gradation. Each rectangle corresponds to value of one sample expression; b , the interaction network between the DEGs and obesity-related genes. Orange indicates DEGs and green indicates obesity-related genes. Cyp17a1, cytochrome P450, family 17, subfamily a, polypeptide 1; Cfd, complement factor D; SAA1, serum amyloid A protein 1; DEGs, differentially expressed genes
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Expressing
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: The insulin resistance in Huh7 cells is suppressed by silencing of SAA1. a , insulin-stimulated 2DG uptake in response to the treatment of PA, insulin and insulin + PA; *, p < 0.05 vs. the blank group; #, p < 0.05 vs. the insulin group; b , Huh7 cell images after PA treatment by oil red O staining (× 200); c , the contents of triglycerides after PA treatment; d , the mRNA expression of SAA1 in PA-treated Huh7 cells according to RT-qPCR; *, p < 0.05 vs. the 0-h group; e , the gray value of SAA1 and β-actin protein bands measured by western blot analysis; f , the protein expression of SAA1 in PA-treated Huh7 cells according to western blot analysis; *, p < 0.05 vs. the 0-h group; g , the mRNA expression of SAA1, IRS1 and SOCS3 in response to the treatment of PA + sh-SAA1, PA + pcDNA3, PA + pcDNA3-SAA1 tested by RT-qPCR; *, p < 0.05 vs. the blank group; #, p < 0.05 vs. the PA + sh-NC group; &, p < 0.05 vs. the PA + pcDNA3 group; h , the gray value of SAA1, IRS1, SOCS3, and p-IRS1 protein bands evaluated by western blot analysis; i , the protein expression of SAA1, IRS1 and SOCS3, and the extent of IRS1 phosphorylation in response to the treatment of PA + sh-SAA1, PA + pcDNA3, PA + pcDNA3-SAA1 according to western blot analysis; *, p < 0.05 vs. the blank group; #, p < 0.05 vs. the PA + sh-NC group; &, p < 0.05 vs. the PA + pcDNA3 group; j , insulin-stimulated 2DG uptake in response to the treatment of insulin + PA + sh-SAA1, insulin + PA + pcDNA3, insulin + PA + pcDNA3-SAA1; *, p < 0.05 vs. the insulin group; #, p < 0.05 vs. the insulin + PA + sh-NC group; data were expressed by means ± standard deviation; differences between two groups were compared by the t test; multiple groups were compared by one-way analysis of variance; the experiment was repeated 3 times; SAA1, serum amyloid A protein 1; 2DG, [ 3 H]2-deoxyglucose uptake; PA, palmitate; RT-qPCR, reverse transcription quantitative polymerase chain reaction; SOCS3, suppressor of cytokine signaling 3; IRS1, insulin receptor substrate 1; p-IRS1, phosphorylation level of IRS1; NC, negative control
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Staining, Expressing, Quantitative RT-PCR, Western Blot, Standard Deviation, Real-time Polymerase Chain Reaction, Negative Control
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: Silencing of SAA1 exerts an inhibitory effect over PA-induced insulin resistance via the activation of the NF-κB pathway. a , the gray value of cytoplasmic p65 and nucleus p65 protein bands according to the western blot analysis; b , the protein expression of cytoplasmic p65 and nucleus p65 in response to the treatment of PA + sh-SAA1, PA + pcDNA3, PA + pcDNA3-SAA1; *, p < 0.05 vs. the blank group; #, p < 0.05 vs. the PA + sh-NC group; &, p < 0.05 vs. the PA + pcDNA3 group; c , the mRNA expression of IRS1 and SOCS3 in response to the treatment of PA + BAY, PA + sh-SAA1 + BAY, PA + pcDNA3-SAA1 + BAY determined by RT-qPCR; *, p < 0.05 vs. the PA group; #, p < 0.05 vs. the PA + BAY group; d , the gray value of IRS1, p-IRS1 and SOCS3 protein bands in response to the treatment of PA + BAY, PA + sh-SAA1 + BAY, PA + pcDNA3-SAA1 + BAY according to the western blot analysis; e , the protein expression of IRS1 and SOCS3, and the extent of IRS1 phosphorylation in response to the treatment of PA + BAY, PA + sh-SAA1 + BAY, PA + pcDNA3-SAA1 + BAY according to western blot analysis; *, p < 0.05 vs. the PA group; #, p < 0.05 vs. the PA + BAY group; f , 2DG uptake in response to the treatment of insulin + PA + BAY, insulin + PA + sh-SAA1 + BAY, insulin + PA + pcDNA3-SAA1 + BAY; p < 0.05 vs. the insulin + PA group; #, p < 0.05 vs. the insulin + PA + BAY group; data were expressed by means ± standard deviation; multiple groups were compared by one-way analysis of variance; the experiment was repeated 3 times; SAA1, serum amyloid A protein 1; NF-κB, nuclear factor-κB; 2DG, [3H]2-Deoxyglucose Uptake; PA, palmitate; RT-qPCR, reverse transcription quantitative polymerase chain reaction; SOCS3, suppressor of cytokine signaling 3; IRS1, insulin receptor substrate 1; p-IRS1, phosphorylated IRS1; NC, negative control
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Activation Assay, Western Blot, Expressing, Quantitative RT-PCR, Standard Deviation, Real-time Polymerase Chain Reaction, Negative Control
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: Glucose tolerance and insulin sensitivity in HFD mice are inhibited by silencing of Saa1. a , body weight changes of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1 at the 0th, 4th, 8th, 12th and 16th week; b , the FBG of HFD mice after 12-h fasting in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1; c , the FPI of HFD mice after 12-h fasting in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1; d , HOMA-insulin resistance of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSAA1 + BAY and HFD + ad-SAA1; e , the blood glucose levels of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1 according to GTT; f , AUC of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-SAA1; g , blood glucose levels of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1 corresponding to insulin resistance test; h , AUC of HFD mice in response to the treatment of HFD + ad-shSaa1, HFD + BAY, HFD + ad-shSaa1 + BAY and HFD + ad-Saa1 corresponding to insulin resistance test; data were expressed by means ± standard deviation; multiple groups were compared by one-way analysis of variance; n = 15; *, p < 0.05 vs. the ND group; #, p < 0.05 vs. the HFD group. Saa1, serum amyloid A protein 1; ND, normal diet; HFD, high-fat diet; GTT, glucose tolerance test; AUC, area under the curve; NC, negative control; FPI, fasting plasma insulin; FBG, fasting blood glucose; HOMA-insulin resistance, homeostasis model assessment of insulin resistance
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Standard Deviation, Negative Control
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: NF-κB pathway is activated by Saa1 in HFD mouse models. a , the grey value of cytoplasmic p65 and nucleus p65 protein bands in liver tissues of HFD mice after fed for 16 weeks, determined by western blot analysis; b , the protein expression of cytoplasmic p65 and nucleus p65 in liver tissues of HFD mice; *, p < 0.05 vs. the ND group; #, p < 0.05 vs. the HFD group; data were expressed by means ± standard deviation; multiple groups were compared by one-way analysis of variance; n = 15; NF-κB, nuclear factor-κB; SAA1, serum amyloid A protein 1; ND, normal diet; HFD, high-fat diet; NC, negative control
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Western Blot, Expressing, Standard Deviation, Negative Control
Journal: Molecular Medicine
Article Title: Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
doi: 10.1186/s10020-019-0075-4
Figure Lengend Snippet: Molecular mechanism map of SAA1 involved in insulin resistance by activating the NF-κB pathway. SAA1 mediates PA- or HFD-induced insulin resistance though the activation of the NF-κB pathway. In PA-or HFD-induced insulin resistance models, up-regulation of SAA1 could inhibit the activation of IRS1 signaling by activating the NF-κB pathway, which contributes to insulin resistance. The silencing of SAA1 or treatment with BAY 11–7082 (NF-κB inhibitor) can relieve PA- or HFD-induced insulin resistance by inhibiting the NF-κB signaling pathway and IRS1 signaling. SAA1, serum amyloid A protein 1; IRS1, insulin receptor substrate 1; NF-κB, nuclear factor-κB; PA, palmitate; HFD, high-fat diet
Article Snippet: Adenoviral vectors expressing shRNA against Saa1 (ad-shSaa1) and
Techniques: Activation Assay